Drug · DIN 02358352
REACTINE FAST MELT JUNIOR
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since March 12, 2026; first marketed March 21, 2014.
- Drug Identification Number (DIN)
- 02358352
- Company (DIN owner)
- Kenvue Canada Inc.Guelph, Ontario, Canada
- Schedule
- Non-prescription drugs
- Dosage form
- Tablet (Orally-Disintegrating)
- Route
- Oral
- Therapeutic class (ATC)
- Cetirizine R06AE07
- Class
- Human
- Record last updated
- March 17, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| CETIRIZINE HYDROCHLORIDE | 10 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- March 12, 2026: NOC 37087New Drug Submission (NDS) · Administrative: Change in manufacturer name
- December 22, 2023: NOC 32428Supplement to a New Drug Submission (SNDS) · Safety update to the Product Monograph
- April 22, 2021: NOC 25735Supplement to a New Drug Submission (SNDS) · Revise labelling to provide clarity on use in the pediatric population
- June 18, 2014: NOC 16002Supplement to a New Drug Submission (SNDS) · Change to the product name from reactine fast melts to reactine fast melt junior and changes to the labelling documents
- October 28, 2010: NOC 11822Supplement to a New Drug Submission (SNDS) · New dosage form